<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Blue Water Ventures International Inc — News on 6ix</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc</link>
<description>Latest news and press releases for Blue Water Ventures International Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 16 May 2024 13:04:46 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/blue-water-ventures-international-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835510278dffbe2df0e7710.webp</url>
<title>Blue Water Ventures International Inc</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc</link>
</image>
<item>
<title>Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences </title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/historical-regulatory-filing-deficiences-continue-to-stifle-psycheceutical-biosciences</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/historical-regulatory-filing-deficiences-continue-to-stifle-psycheceutical-biosciences</guid>
<pubDate>Thu, 16 May 2024 13:04:46 GMT</pubDate>
<description>Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences.</description>
</item>
<item>
<title>Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-strategically-pivots-into-the-brain-computer-interface-bci-space</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-strategically-pivots-into-the-brain-computer-interface-bci-space</guid>
<pubDate>Wed, 17 Jan 2024 13:01:53 GMT</pubDate>
<description>Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space.</description>
</item>
<item>
<title>Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/dr-neilank-jha-appointed-as-executive-chairman-and-chief-executive-officer-of-psycheceutical-bioscience-inc</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/dr-neilank-jha-appointed-as-executive-chairman-and-chief-executive-officer-of-psycheceutical-bioscience-inc</guid>
<pubDate>Tue, 12 Dec 2023 14:01:23 GMT</pubDate>
<description>Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc..</description>
</item>
<item>
<title> Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-launches-wefunder-crowdfunding-campaign-for-safer-psychedelic-dosing</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-launches-wefunder-crowdfunding-campaign-for-safer-psychedelic-dosing</guid>
<pubDate>Wed, 01 Nov 2023 12:02:33 GMT</pubDate>
<description>Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing.</description>
</item>
<item>
<title>Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-announces-successful-first-cohort-dosing-moves-to-dose-escalation-in-phase-i-trial-of-neurodirect-ketamine-for-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-announces-successful-first-cohort-dosing-moves-to-dose-escalation-in-phase-i-trial-of-neurodirect-ketamine-for-ptsd</guid>
<pubDate>Thu, 10 Aug 2023 12:31:46 GMT</pubDate>
<description>Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD.</description>
</item>
<item>
<title>Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-announces-completion-of-pcaob-audit-and-future-corporation-action-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-announces-completion-of-pcaob-audit-and-future-corporation-action-strategy</guid>
<pubDate>Tue, 01 Aug 2023 14:36:49 GMT</pubDate>
<description>Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy.</description>
</item>
<item>
<title>First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/first-patient-dosed-in-psycheceuticals-phase-i-study-exploring-topical-administration-of-ketamine-to-treat-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/first-patient-dosed-in-psycheceuticals-phase-i-study-exploring-topical-administration-of-ketamine-to-treat-ptsd</guid>
<pubDate>Thu, 13 Jul 2023 12:01:22 GMT</pubDate>
<description>First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD.</description>
</item>
<item>
<title>Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-secures-funding-for-clinical-trials-of-neurodirecttm-ketamine-topical-to-treat-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-secures-funding-for-clinical-trials-of-neurodirecttm-ketamine-topical-to-treat-ptsd</guid>
<pubDate>Thu, 01 Jun 2023 14:01:46 GMT</pubDate>
<description>Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD.</description>
</item>
<item>
<title>The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/the-next-generation-of-mental-health-treatment-psycheceutical-bioscience-incs-otcpkbwvi-novel-topical-ketamine-delivery</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/the-next-generation-of-mental-health-treatment-psycheceutical-bioscience-incs-otcpkbwvi-novel-topical-ketamine-delivery</guid>
<pubDate>Tue, 18 Apr 2023 13:01:03 GMT</pubDate>
<description>The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery.</description>
</item>
<item>
<title>Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-inc-named-a-2023-top-10-biotech-startup-by-life-sciences-review</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-inc-named-a-2023-top-10-biotech-startup-by-life-sciences-review</guid>
<pubDate>Thu, 13 Apr 2023 14:01:32 GMT</pubDate>
<description>Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review.</description>
</item>
<item>
<title>Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-hosts-maps-founder-and-psychedelic-industry-leader-rick-doblin-at-its-drug-development-lab</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-hosts-maps-founder-and-psychedelic-industry-leader-rick-doblin-at-its-drug-development-lab</guid>
<pubDate>Wed, 29 Mar 2023 17:41:34 GMT</pubDate>
<description>Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab.</description>
</item>
<item>
<title>Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-inc-announces-observational-research-results-for-neurodirecttm-ketamine-topical-cream-in-treating-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-inc-announces-observational-research-results-for-neurodirecttm-ketamine-topical-cream-in-treating-ptsd</guid>
<pubDate>Tue, 21 Mar 2023 16:50:06 GMT</pubDate>
<description>Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD.</description>
</item>
<item>
<title>Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-to-conduct-the-first-ever-phase-i-and-ii-clinical-trials-of-a-novel-ketamine-topical-cream-to-treat-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-to-conduct-the-first-ever-phase-i-and-ii-clinical-trials-of-a-novel-ketamine-topical-cream-to-treat-ptsd</guid>
<pubDate>Wed, 15 Feb 2023 16:30:11 GMT</pubDate>
<description>Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD.</description>
</item>
<item>
<title>Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-announces-completion-of-pre-ind-meeting-with-fda-for-topical-ketamine-drug-to-treat-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-announces-completion-of-pre-ind-meeting-with-fda-for-topical-ketamine-drug-to-treat-ptsd</guid>
<pubDate>Thu, 02 Feb 2023 15:20:39 GMT</pubDate>
<description>Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD.</description>
</item>
<item>
<title>Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-provisional-patent-application-for-novel-ketamine-topical-for-the-treatment-of-ptsd</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-provisional-patent-application-for-novel-ketamine-topical-for-the-treatment-of-ptsd</guid>
<pubDate>Thu, 26 Jan 2023 17:15:37 GMT</pubDate>
<description>Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD.</description>
</item>
<item>
<title>Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-announces-julian-bailes-md-as-board-member-and-chief-medical-officer</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-announces-julian-bailes-md-as-board-member-and-chief-medical-officer</guid>
<pubDate>Tue, 10 Jan 2023 19:06:08 GMT</pubDate>
<description>Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer.</description>
</item>
<item>
<title>Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/dr-aric-logsdon-joins-psycheceutical-bioscience-inc-as-companys-scientific-director</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/dr-aric-logsdon-joins-psycheceutical-bioscience-inc-as-companys-scientific-director</guid>
<pubDate>Tue, 29 Nov 2022 16:35:36 GMT</pubDate>
<description>Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director.</description>
</item>
<item>
<title>Psycheceutical Bioscience, Inc. Announces Medical Advisory Board</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-inc-announces-medical-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-inc-announces-medical-advisory-board</guid>
<pubDate>Tue, 18 Oct 2022 14:15:46 GMT</pubDate>
<description>Psycheceutical Bioscience, Inc. Announces Medical Advisory Board.</description>
</item>
<item>
<title>Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-incs-zappy-zapolin-added-to-the-benzinga-psychedelics-advisory-council</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/psycheceutical-bioscience-incs-zappy-zapolin-added-to-the-benzinga-psychedelics-advisory-council</guid>
<pubDate>Tue, 04 Oct 2022 14:14:40 GMT</pubDate>
<description>Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council.</description>
</item>
<item>
<title>Watch the Psycheceutical Bioscience, Inc. Presentation at the September 15, 2022 Life Sciences Investor Forum</title>
<link>https://6ix.com/company/blue-water-ventures-international-inc/news/watch-the-psycheceutical-bioscience-inc-presentation-at-the-september-15-2022-life-sciences-investor-forum</link>
<guid isPermaLink="true">https://6ix.com/company/blue-water-ventures-international-inc/news/watch-the-psycheceutical-bioscience-inc-presentation-at-the-september-15-2022-life-sciences-investor-forum</guid>
<pubDate>Fri, 16 Sep 2022 13:00:00 GMT</pubDate>
<description>Watch the Psycheceutical Bioscience, Inc. Presentation at the September 15, 2022 Life Sciences Investor Forum.</description>
</item>
</channel>
</rss>